Article

X-chromosome epigenetic reprogramming in pluripotent stem cells via noncoding genes.

Division of Biology, California Institute of Technology, 1200 E. California Blvd., Pasadena, CA 91125, USA.
Seminars in Cell and Developmental Biology (impact factor: 6.65). 03/2011; 22(4):336-42. DOI:10.1016/j.semcdb.2011.02.025 pp.336-42
Source: PubMed

ABSTRACT Acquisition of the pluripotent state coincides with epigenetic reprogramming of the X-chromosome. Female embryonic stem cells are characterized by the presence of two active X-chromosomes, cell differentiation by inactivation of one of the two Xs, and induced pluripotent stem cells by reactivation of the inactivated X-chromosome in the originating somatic cell. The tight linkage between X- and stem cell reprogramming occurs through pluripotency factors acting on noncoding genes of the X-inactivation center. This review article will discuss the latest advances in our understanding at the molecular level. Mouse embryonic stem cells provide a standard for defining the pluripotent ground state, which is characterized by low levels of the noncoding Xist RNA and the absence of heterochromatin marks on the X-chromosome. Human pluripotent stem cells, however, exhibit X-chromosome epigenetic instability that may have implications for their use in regenerative medicine. XIST RNA and heterochromatin marks on the X-chromosome indicate whether human pluripotent stem cells are developmentally 'naïve', with characteristics of the pluripotent ground state. X-chromosome status and determination thereof via noncoding RNA expression thus provide valuable benchmarks of the epigenetic quality of pluripotent stem cells, an important consideration given their enormous potential for stem cell therapy.

0 0
 · 
0 Bookmarks
 · 
105 Views
  • Source
    Article: X chromosome dosage compensation: how mammals keep the balance.
    [show abstract] [hide abstract]
    ABSTRACT: The development of genetic sex determination and cytologically distinct sex chromosomes leads to the potential problem of gene dosage imbalances between autosomes and sex chromosomes and also between males and females. To circumvent these imbalances, mammals have developed an elaborate system of dosage compensation that includes both upregulation and repression of the X chromosome. Recent advances have provided insights into the evolutionary history of how both the imprinted and random forms of X chromosome inactivation have come about. Furthermore, our understanding of the epigenetic switch at the X-inactivation center and the molecular aspects of chromosome-wide silencing has greatly improved recently. Here, we review various facets of the ever-expanding field of mammalian dosage compensation and discuss its evolutionary, developmental, and mechanistic components.
    Annual Review of Genetics 09/2008; 42:733-72. · 22.23 Impact Factor
  • Article: A new model for random X chromosome inactivation.
    [show abstract] [hide abstract]
    ABSTRACT: X chromosome inactivation (XCI) reduces the number of actively transcribed X chromosomes to one per diploid set of autosomes, allowing for dosage equality between the sexes. In eutherians, the inactive X chromosome in XX females is randomly selected. The mechanisms for determining both how many X chromosomes are present and which to inactivate are unknown. To understand these mechanisms, researchers have created X chromosome mutations and transgenes. Here, we introduce a new model of X chromosome inactivation that aims to account for the findings in recent studies, to promote a re-interpretation of existing data and to direct future experiments.
    Development 12/2008; 136(1):1-10. · 6.60 Impact Factor
  • Article: Lessons from X-chromosome inactivation: long ncRNA as guides and tethers to the epigenome.
    [show abstract] [hide abstract]
    ABSTRACT: Transcriptome studies are revealing that the eukaryotic genome actively transcribes a diverse repertoire of large noncoding RNAs (ncRNAs), many of which are unannotated and distinct from the small RNAs that have garnered much attention in recent years. Why are they so pervasive, and do they have a function? X-chromosome inactivation (XCI) is a classic epigenetic phenomenon associated with many large ncRNAs. Here, I provide a perspective on how XCI is achieved in mice and suggest how this knowledge can be applied to the rest of the genome. Emerging data indicate that long ncRNAs can function as guides and tethers, and may be the molecules of choice for epigenetic regulation: First, unlike proteins and small RNAs, large ncRNAs remain tethered to the site of transcription, and can therefore uniquely direct allelic regulation. Second, ncRNAs command a much larger sequence space than proteins, and can therefore achieve very precise spatiotemporal control of development. These properties imply that long noncoding transcripts may ultimately rival small RNAs and proteins in their versatility as epigenetic regulators, particularly for locus- and allele-specific control.
    Genes & development 09/2009; 23(16):1831-42. · 12.08 Impact Factor

Full-text

View
0 Downloads
Available from

Keywords

active X-chromosomes
 
cell reprogramming
 
cell therapy
 
epigenetic quality
 
epigenetic reprogramming
 
exhibit X-chromosome epigenetic instability
 
Female embryonic
 
inactivated X-chromosome
 
molecular level
 
Mouse embryonic
 
noncoding genes
 
noncoding RNA expression
 
noncoding Xist RNA
 
originating somatic cell
 
pluripotency factors
 
pluripotent ground state
 
pluripotent state coincides
 
X-chromosome status
 
X-inactivation center
 
XIST RNA
 

Daniel H Kim